CTRI/2022/03/041079尚未招募2 期
â?? Randomised Controlled Trial on Shuddha Guggulu in Sandhigatvat WSR to Osteoarthritis Specifically on WOMAC Scale
Government Ayurved College and Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1)Patient willing and able to participate in the study.
- •2)Patients who have not participated in any research projects since last 6 months.
- •3)Patients presenting with signs and symptoms of Osteoarthrities mentioned in classics.
- •4)Patients of either sex aged between 30-70years.
- •5)Patients of Sandhigata Vata presenting clinical features and having symptoms of Sama Vayu described in criteria of diagnosis, will be selected irrespective of sex, caste, religion, socio-economic and educational status. As well as BMI more than 23 will also be taken in to account.
- •6)Patients willing and able to participate for 6 weeks
- •7)Controlled systemic disease such as diabetes and hypertension.
排除标准
- •1)Immune-compromised patients.
- •2)Uncontrolled diabetes mellitus and hypertension.
- •3)Patients with evidence of malignancy.
- •4)Patients who had undergone major surgery within 2 weeks prior to screening visit.
- •5)Pregnant and lactating mother.
- •6)Patients having history of tubercular, gouty and infective arthritis.
- •7)Patients with any serious life threatening disorder.
- •8)Any other patient whom investigator feels not to be recruited due any reasons evident at the time of recruitment
研究者
相似试验
进行中（未招募）
1 期
This is a study to Evaluate the Safety and Efficacy of ABBV-154 in Subjects with Moderately to Severely Active Crohn's Disease (CD)Subjects with moderately to severely active Crohn's diseaseMedDRA version: 20.0Level: PTClassification code 10011401Term: Crohn's diseaseSystem Organ Class: 10017947 - Gastrointestinal disordersEUCTR2021-002869-18-BEAbbVie Deutschland GmbH & Co. KG265
进行中（未招募）
1 期
Clinical Trial to compare if seriously-ill adults with constipation due to narcotics have bowel movements sooner after injection with Methylnatrexone or placeboEUCTR2007-000854-30-BESalix Pharmaceuticals Inc254
进行中（未招募）
不适用
A study to evaluate the effect and safety of a 4 week treatment plan of Alirocumab in patients with high cholesterolPrimary HypercholesterolemiaMedDRA version: 17.0Level: LLTClassification code 10020604Term: HypercholesterolemiaSystem Organ Class: 100000004861EUCTR2013-002343-29-GBRegeneron Pharmaceuticals, Inc.803
进行中（未招募）
不适用
A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Tolerability of E5555, and its Effects on Markers of Intravascular Inflammation in Subjects with Coronary Artery Disease - E5555-G000-201Coronary Artery DiseaseMedDRA version: 8.1Level: PTClassification code 10011078EUCTR2005-006029-94-BEEisai Limited720
已完成
不适用
A Randomized, Double-Blind, Placebo-Controlled Study in Healthy Male Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Ascending Oral Doses of JNJ-26070109abdominal pain and heartburn10017943NL-OMON30044Janssen-Cilag82